SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, today announced a multi-year ...

For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Cleveland Clinic researchers found that genetic testing could identify HPV-positive throat cancer patients who may safely ...

Former nurse at Northwest Hospital (now part of UW Medicine) and its proton therapy facility, Gayle, had multiple treatments ...

RADX READ THE FULL RADX RESEARCH REPORT Radiopharm Theranostics Limited (NASDAQ:RADX) held another key opinion leader (KOL) ...

Leo Cancer Care today confirmed an expansion of its collaboration with IHH Healthcare to bring upright radiotherapy solutions to its ...

For nearly two decades, just a passing mention of Erin Sullivan-Wagner's cancer was enough to 'quiet a room.' At the end of 2007, the Iowa mother-of-four had noticed specks of blood dotting her toilet ...

Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN FRANCISCO, Sept. 29, 2025 ...

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found ...